These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 26854469)

  • 1. Disulfide subproteome alterations in the platelets of patients with myelodysplastic syndrome.
    Pecankova K; Majek P; Cermak J; Dyr JE
    J BUON; 2015; 20(6):1643-4. PubMed ID: 26854469
    [No Abstract]   [Full Text] [Related]  

  • 2. [Blood platelet function in chronic myeloid disorders. II. Myelodysplastic syndromes].
    Cieslar P; Matousová O
    Vnitr Lek; 1988 May; 34(5):441-8. PubMed ID: 3414027
    [No Abstract]   [Full Text] [Related]  

  • 3. Oxidative stress in red blood cells, platelets and polymorphonuclear leukocytes from patients with myelodysplastic syndrome.
    Ghoti H; Amer J; Winder A; Rachmilewitz E; Fibach E
    Eur J Haematol; 2007 Dec; 79(6):463-7. PubMed ID: 17976187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet survival in myelodysplastic syndromes.
    Efira A; Cauchie P; Rauis M; de Maertelaere E
    Acta Haematol; 1986; 76(2-3):124-6. PubMed ID: 3101349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet apoptosis and agonist-mediated activation in myelodysplastic syndromes.
    Martín M; de Paz R; Jiménez-Yuste V; Fernández Bello I; García Arias Salgado E; Alvarez MT; Butta NV
    Thromb Haemost; 2013 May; 109(5):909-19. PubMed ID: 23407717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ballooning platelets in the myelodysplastic syndromes (MDS).
    Jakobsen PE; Hansen JB; Pedersen JO; Jensen MK; Nielsen LC
    Eur J Haematol; 1994 Sep; 53(3):175-7. PubMed ID: 7925861
    [No Abstract]   [Full Text] [Related]  

  • 7. Platelet dysfunction in acute leukemias and myelodysplastic syndromes.
    Vlădăreanu AM; Vasilache V; Bumbea H; Onisâi M
    Rom J Intern Med; 2011; 49(1):93-6. PubMed ID: 22026258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet mass has prognostic value in patients with myelodysplastic syndromes.
    Bowles KM; Warner BA; Baglin TP
    Br J Haematol; 2006 Oct; 135(2):198-200. PubMed ID: 16939490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet morphology, platelet mass, platelet count and prognosis in patients with myelodysplastic syndromes.
    Germing U; Platzbecker U; Giagounidis A; Aul C
    Br J Haematol; 2007 Aug; 138(3):399-400. PubMed ID: 17555472
    [No Abstract]   [Full Text] [Related]  

  • 10. Platelet function in the myelodysplastic syndromes.
    Rasi V; Lintula R
    Scand J Haematol Suppl; 1986; 45():71-3. PubMed ID: 3515523
    [No Abstract]   [Full Text] [Related]  

  • 11. Usefulness of immature platelet fraction for the clinical evaluation of myelodysplastic syndromes.
    Saigo K; Takenokuchi M; Imai J; Numata K; Isono S; Zenibayashi M; Tanioka H; Yoshioka T; Nishizawa A; Takada M; Nomura T; Kubota Y
    Lab Hematol; 2009; 15(2):13-6. PubMed ID: 19561008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-6 may play an important role in thrombopoiesis: a case of leukemic transformation from myelodysplastic syndrome.
    Ota T; Hino M; Yamane T; Ota K; Mugitani A; Park K; Im T; Takubo T; Tatsumi N
    Ann Hematol; 1998 Nov; 77(5):243-4. PubMed ID: 9858152
    [No Abstract]   [Full Text] [Related]  

  • 13. [Morphological analysis of the megakaryocytes in myelodysplastic syndrome].
    Mori H; Niikura H; Terada H; Fujita K
    Rinsho Byori; 1990 Dec; 38(12):1347-52. PubMed ID: 2082033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Myelodysplastic syndromes].
    Sainty D; Horschowski N; Fossat C; Sampol J
    Ann Biol Clin (Paris); 1985; 43(6):821-30. PubMed ID: 3914223
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hemorheologic study in myelodysplastic syndrome].
    Rohrberg R; Sternitzky R
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(1):75-80. PubMed ID: 2472331
    [No Abstract]   [Full Text] [Related]  

  • 16. [Ferritin levels of the serum and red blood cells in patients with myelodysplastic syndrome (MDS)].
    Sakurada K; Miyazaki T
    Rinsho Ketsueki; 1986 Sep; 27(9):1789-95. PubMed ID: 3806987
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of interleukin-11 to stimulate platelet production in myelodysplastic syndromes.
    Valent P
    Leuk Lymphoma; 2006 Oct; 47(10):1999-2001. PubMed ID: 17071464
    [No Abstract]   [Full Text] [Related]  

  • 18. Myelodysplastic syndrome with isolated 5q deletion (5q- syndrome). A clonal stem cell disorder characterized by defective ribosome biogenesis.
    Cazzola M
    Haematologica; 2008 Jul; 93(7):967-72. PubMed ID: 18591621
    [No Abstract]   [Full Text] [Related]  

  • 19. A patient with Tn syndrome associated with myelodysplastic syndrome showed abnormal glycophorin B.
    Kamesaki T; Akifuji Y; Mori M; Ueki J; Nakamoto S; Kajii E; Ikemoto S
    Int J Hematol; 1993 Aug; 58(1-2):113-8. PubMed ID: 8219107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An association of polymyalgia rheumatica with myelodysplastic syndromes.
    Kohli M; Bennett RM
    J Rheumatol; 1994 Jul; 21(7):1357-9. PubMed ID: 7966085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.